Lantheus Holdings Logo

Lantheus Holdings

🇺🇸
LNTH
US5165441032

Lantheus Holdings is a US-based pharmaceutical company that develops and commercializes innovative diagnostics and therapeutics. The company focuses on medical imaging and radiopharmaceuticals to improve the detection and treatment of cancer and heart disease. Lantheus significantly contributes to patient care worldwide by offering targeted drugs and diagnostic solutions.

Next Quarterly Earnings

Thursday, July 30, 2026
CW 31
Pre-Market
In 25 days

Stock Price

All Dates

Company Information

Name
Lantheus Holdings
Ticker Symbol
LNTH
ISIN
US5165441032
Country
🇺🇸
USA